Large-scale testing (Phase 3)Ended earlyNCT00679484
What this trial is testing
Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24
Who this might be right for
Chronic Heart FailureHigh Blood B-type (or Brain) Natriuretic Peptide (BNP) Level
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 400